Inventor · disambiguated record
Benjamin E. Blass
Also filed as: BLASS BENJAMIN · BLASS BENJAMIN E · BLASS BENJAMIN ERIC
33 granted patents·9 pending applications·167 citations·filing 2000–2025
97Inventor score
Files withUNIV TEMPLE17TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION7BIOHAVEN PHARM HOLDING CO LTD5CORTENDO AB PUBL4PROCTER & GAMBLE4
Top patents by PatentIndex Score
42 records- 0195US11897870B25-hydroxytryptamine receptor 7 activity modulators and their method of useUNIV TEMPLE·Filed 2020·Granted Feb 13, 2024·4 cites·7 claims
- 0295US9725427B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2013·Granted Aug 8, 2017·20 cites·11 claims
- 0394US11319327B2Modulators of the 5-hydroxytryptamine receptor 7 and their method of useTemple University—Of the Commonwealth System of Higher Education·Filed 2020·Granted May 3, 2022·6 cites·12 claims
- 0493US10676464B25-hydroxytryptamine receptor 7 activity modulators and their method of useUNIV TEMPLE·Filed 2019·Granted Jun 9, 2020·6 cites·18 claims
- 0592US11440893B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Sep 13, 2022·2 cites·5 claims
- 0692US10858368B2Modulators of the 5-hydroxytryptamine receptor 7 and their method of useTemple University—Of the Commonwealth System of Higher Education·Filed 2017·Granted Dec 8, 2020·6 cites·25 claims
- 0791US11807642B25-hydroxytryptamine receptor 7 modulators and their use as therapeutic agentsTemple University—Of the Commonwealth System of Higher Education·Filed 2021·Granted Nov 7, 2023·2 cites·13 claims
- 0890US11820774B2Modulators of the sigma-2 receptor and their method of useTemple University—Of the Commonwealth System of Higher Education·Filed 2021·Granted Nov 21, 2023·2 cites·6 claims
- 0990US10961249B2Modulators of the sigma-2 receptor and their method of useUNIV TEMPLE·Filed 2018·Granted Mar 30, 2021·7 cites·15 claims
- 1090US10844026B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Nov 24, 2020·2 cites·7 claims
- 1190US10131637B2Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Nov 20, 2018·10 cites·6 claims
- 1288US10562870B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2017·Granted Feb 18, 2020·2 cites·3 claims
- 1388US10287274B25-hydroxytryptamine receptor 7 activity modulators and their method of useUNIV TEMPLE·Filed 2017·Granted May 14, 2019·5 cites·13 claims
- 1488US10239868B25-hydroxytryptamine receptor 7 activity modulators and their method of useUNIV TEMPLE·Filed 2017·Granted Mar 26, 2019·6 cites·13 claims
- 1588US9802924B25-hydroxytryptamine receptor 7 activity modulators and their method of useUNIV TEMPLE·Filed 2014·Granted Oct 31, 2017·10 cites·3 claims
- 1687US12503458B25-hydroxytryptamine receptor 7 activity modulators and their method of useUNIV TEMPLE·Filed 2023·Granted Dec 23, 2025·0 cites·5 claims
- 1785US11192871B25-hydroxytryptamine receptor 7 activity modulators and their method of useUNIV TEMPLE·Filed 2019·Granted Dec 7, 2021·4 cites·4 claims
- 1885US10544117B25-hydroxytryptamine receptor 7 activity modulators and their method of useTemple University—Of the Commonwealth System of Higher Education·Filed 2015·Granted Jan 28, 2020·5 cites·2 claims
- 1985US6787555B2Triazole compounds useful in treating diseases associated with unwanted cytokine activityPROCTER & GAMBLE·Filed 2002·Granted Sep 7, 2004·24 cites·9 claims
- 2085US6727364B2Triazole compounds useful in treating diseases associated with unwanted cytokine activityPROCTER & GAMBLE·Filed 2002·Granted Apr 27, 2004·29 cites·1 claims
- 2182US12172974B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2022·Granted Dec 24, 2024·0 cites·8 claims
- 2281US2025282790A1Novel modulators of the 5-hydroxytryptamine receptor 7 and their method of useUNIV TEMPLE·Filed 2025·Application pending·0 cites
- 2380US11220505B25-hydroxytryptamine receptor 7 modulators and their use as therapeutic agentsUNIV TEMPLE·Filed 2018·Granted Jan 11, 2022·3 cites·13 claims
- 2480US9464062B2Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulatorsTemple University—Of the Commonwealth System of Higher Education·Filed 2013·Granted Oct 11, 2016·4 cites·14 claims
- 2578US12338247B2Modulators of the 5-hydroxytryptamine receptor 7 and their method of useUNIV TEMPLE·Filed 2022·Granted Jun 24, 2025·0 cites·15 claims
- 2677US12338245B25-hydroxytryptamine receptor 7 modulators and their use as therapeutic agentsUNIV TEMPLE·Filed 2023·Granted Jun 24, 2025·0 cites·9 claims
- 2774US12269809B25-hydroxytryptamine receptor 7 activity modulators and their method of useUNIV TEMPLE·Filed 2021·Granted Apr 8, 2025·0 cites·21 claims
- 2871US10759750B2Beta lactams as modulators of glutamate uptake and methods for use thereofTemple University—Of the Commonwealth System of Higher Education·Filed 2017·Granted Sep 1, 2020·1 cites·25 claims
- 2970US9975879B2Beta lactams as modulators of glutamate uptake and methods for use thereofUNIV TEMPLE·Filed 2014·Granted May 22, 2018·2 cites·9 claims
- 3070US6635769B1Process for making functionalized oxazolidinone compoundsPROCTER & GAMBLE·Filed 2000·Granted Oct 21, 2003·4 cites·5 claims
- 3162US2022133713A1Sigma-2 receptor binders and their method of useUNIV TEMPLE·Filed 2021·Application pending·0 cites
- 3258US6596739B2N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and usesPROCTER & GAMBLE·Filed 2000·Granted Jul 22, 2003·1 cites·18 claims
- 3357US7504517B2Kv1.5 potassium channel inhibitorsWYETH CORP·Filed 2007·Granted Mar 17, 2009·0 cites·30 claims
- 3456US7803827B2Kv1.5 potassium channel inhibitorsWYETH LLC·Filed 2008·Granted Sep 28, 2010·0 cites·69 claims
- 3555US2018079730A1Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2017·Application pending·0 cites
- 3650US2023002383A1Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of useUNIV TEMPLE·Filed 2020·Application pending·0 cites
- 3745US9725436B2Cytochrome P450 inhibitors and their method of useCORTENDO AB (PUBL)·Filed 2014·Granted Aug 8, 2017·0 cites·13 claims
- 3845US2016244436A1Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibiting cytochrome p450 inhibition and their method of useCORTENDO AB (PUBL)·Filed 2014·Application pending·0 cites
- 3944US2015353530A1Novel functionalized 4-(phenoxymethyl(-1,3-dioxolane analogs exhibiting cytochrome p450 inhibition and their method of useCORTENDO AB PUBL·Filed 2014·Application pending·0 cites
- 4042US2018221365A1Novel sigma-2 receptor binders and their method of useUNIV TEMPLE·Filed 2016·Application pending·0 cites
- 4141US2007299072A1Kv1.5 potassium channel inhibitorsWYETH CORP·Filed 2007·Application pending·0 cites
- 4231US2015210641A1Novel cytochrome p450 inhibitors and their method of useCORTENDO AB PUBL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Benjamin E. Blass files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →